The biopharma industry is evolving, with increased focus on partnerships, early-phase deal-making and technologies like AI and machine learning. At this year’s BIO-Europe conference in Stockholm, Norstella’s subject matter experts joined discussions on key topics, including a roundtable on the future of precision medicine and a panel on the pharma patent cliff, highlighting the role of collaboration and data-driven strategies in tackling industry challenges.
Following the event, Izabela Chmielewska, Citeline’s managing editor of custom content, hosted a podcast with Kevin Grogan, managing editor of Scrip and Natasha Choukkar, senior manager of portfolio advisory strategy consulting at Evaluate, to share insights on advancing personalized treatments and sustaining growth through innovation.
The conversation underscored how Norstella’s data, analytics, and consulting capabilities support organizations in addressing challenges and capturing opportunities in an ever-changing landscape.
